MX2009006438A - Genes de exon unico que codifican nuevos peptidos bioactivos. - Google Patents

Genes de exon unico que codifican nuevos peptidos bioactivos.

Info

Publication number
MX2009006438A
MX2009006438A MX2009006438A MX2009006438A MX2009006438A MX 2009006438 A MX2009006438 A MX 2009006438A MX 2009006438 A MX2009006438 A MX 2009006438A MX 2009006438 A MX2009006438 A MX 2009006438A MX 2009006438 A MX2009006438 A MX 2009006438A
Authority
MX
Mexico
Prior art keywords
new bioactive
coding genes
bioactive peptides
single exon
present
Prior art date
Application number
MX2009006438A
Other languages
English (en)
Inventor
Eva Jung
Werner Dittrich
Sabine Scheidler
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of MX2009006438A publication Critical patent/MX2009006438A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/515—Angiogenesic factors; Angiogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Physics & Mathematics (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)

Abstract

La presente invención se refiere a nueva hormona peptídica bioactiva, a un procedimiento para la producción de la misma, y al uso de la misma; la presente invención identificó nuevos precursores de péptidos bioactivos y sales de los mismos que pueden ser empleados como fármacos, por ejemplo polipéptidos terapéuticos, ligandos para caracterizar dianas relevantes (por ejemplo GPCRs) o dianas para la intervención farmacológica.
MX2009006438A 2006-12-19 2007-12-12 Genes de exon unico que codifican nuevos peptidos bioactivos. MX2009006438A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006059825 2006-12-19
PCT/EP2007/010842 WO2008074424A2 (de) 2006-12-19 2007-12-12 Gene mit einem einzigen exon, die für neue bioaktive peptide kodieren

Publications (1)

Publication Number Publication Date
MX2009006438A true MX2009006438A (es) 2009-08-07

Family

ID=39446236

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009006438A MX2009006438A (es) 2006-12-19 2007-12-12 Genes de exon unico que codifican nuevos peptidos bioactivos.

Country Status (13)

Country Link
US (1) US20100184660A1 (es)
EP (1) EP2114997A2 (es)
JP (1) JP2010512763A (es)
KR (1) KR20090100359A (es)
CN (1) CN101600734A (es)
AR (1) AR064390A1 (es)
AU (1) AU2007334933B2 (es)
BR (1) BRPI0721282A2 (es)
CA (1) CA2672945A1 (es)
IL (1) IL225806A0 (es)
MX (1) MX2009006438A (es)
TW (1) TW200846467A (es)
WO (1) WO2008074424A2 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004039956A2 (en) * 2002-10-29 2004-05-13 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
US9587222B2 (en) * 2003-08-01 2017-03-07 Cellseed Inc. Three-dimensional tissue structure
DE102006021257A1 (de) * 2006-04-28 2007-11-08 Eberhard-Karls-Universität Tübingen Universitätsklinikum Nachweis von transgener DNA (t DNA)

Also Published As

Publication number Publication date
AU2007334933B2 (en) 2014-01-30
IL225806A0 (en) 2013-06-27
CN101600734A (zh) 2009-12-09
BRPI0721282A2 (pt) 2014-04-08
TW200846467A (en) 2008-12-01
EP2114997A2 (de) 2009-11-11
CA2672945A1 (en) 2008-06-26
JP2010512763A (ja) 2010-04-30
WO2008074424A3 (de) 2008-10-23
KR20090100359A (ko) 2009-09-23
US20100184660A1 (en) 2010-07-22
WO2008074424A2 (de) 2008-06-26
AR064390A1 (es) 2009-04-01
AU2007334933A1 (en) 2008-06-26

Similar Documents

Publication Publication Date Title
MY171146A (en) Compositions of glp-1 peptides and preparation thereof
MX2021012106A (es) Factores de coagulacion de accion prolongada y metodos de produccion de los mismos.
MX2019000708A (es) Factores de coagulacion de accion prolongada y metodos de produccion de los mismos.
JO3323B1 (ar) صور جرعة صيدلانية
EP2215107A4 (en) DRUG DELIVERY DIRECTED BY A PEPTIDE LIGAND
ZA201003019B (en) Pharmaceutical compositions comprising glp-1 peptides or exendin-4 and a basal insulin peptide
AR093903A1 (es) Coagonistas de glucagon y glp-1 para el tratamiento de la obesidad
PT2152195E (pt) Produto farmacêutico peptídico para distribuição oral
IL193846A (en) Use of a n-terminal peptide that has been re-regulated to produce a drug to treat inflammatory conditions
MX344219B (es) Productos farmaceuticos peptidicos mejorados para resistencia a insulina.
WO2010115033A3 (en) Nucleotide repeat expansion-associated polypeptides and uses thereof
WO2008087186A3 (en) Peptides for use in the treatment of obesity
WO2010111617A3 (en) Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use
WO2007092370A3 (en) Lingo-1 structure
WO2012048294A3 (en) Pharmaceutical compositions for treating chronic pain and pain associated with neuropathy
MX342171B (es) Peptido o complejo peptidico que se une a integrina ?2 y metodos y usos que implican a los mismos.
NZ726623A (en) Improved peptide pharmaceuticals for insulin resistance
WO2008087188A3 (en) Peptides for use in the treatment of obesity
WO2011038900A3 (en) Peptide analogues of glucagon for diabetes therapy
AU2011354262A8 (en) Alphabody libraries and methods for producing the same
WO2008087189A3 (en) Peptides for use in the treatment of obesity
ZA200807027B (en) Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition
MX2012013710A (es) Peptidos de union al receptor del factor 1 de crecimiento similar a la insulina.
JP2017517561A5 (es)
EP3026057A3 (en) Compositions for prevention and treatment of neurodegenerative diseases

Legal Events

Date Code Title Description
FG Grant or registration